Clinical Trial: "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Focal Subthreshold Laser Treatment for Macular Drusen
Brief Summary: This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.
Detailed Summary: SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
Sponsor: Seoul National University Bundang Hospital
Current Primary Outcome: Change in drusen size [ Time Frame: 3 month interval ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Best Corrected Visual Acuity (BCVA) [ Time Frame: 3 months interval ]ETDRS and Snellen visual acuity measurement
- Change in drusen distribution [ Time Frame: 3 month interval ]
- Change in autofluorescence [ Time Frame: 3 month interval ]
- Choroidal Neovascularization [ Time Frame: 3 months interval ]
- Contrast Sensitivity [ Time Frame: 3 months interval ]Contrast Sensitivity Test
Original Secondary Outcome: Same as current
Information By: Seoul National University Bundang Hospital
Dates:
Date Received: June 30, 2016
Date Started: January 2016
Date Completion: June 2019
Last Updated: November 9, 2016
Last Verified: November 2016